1/ Paper alert: Introducing Solly, the first AI to achieve elite human level performance at Liar’s Poker, the classic Wall Street bluffing game. With @Ciamac, @atzheng and Janos Botyanszki.

Releasing two new models today: VariantFormer and scLDM Our goal at Biohub is to advance virtual biology by merging frontier biology with frontier AI models. Here's what's new from my team:

⚠️CAUTION: SHOCKING CONTENT The cover-up is always worse than the crime... and this crime is pure evil. This 2-minute clip comes from the verbatim film 'The Grooming Gangs Cover-Up,' which details the heinous acts done to children uncovered at trial. @elonmusk @DominicFrisby

we're hiring for a senior computational scientist at @NOETIK_ai. this is a very multidisciplinary role, and will involve everything from foundation model inference to clinical trial simulations to tumor microenvironment analysis you dont need to know how to do everything! we are

I am in the Bay Area for the whole next week and would be excited to chat with anyone about the future of biomolecular design! Let me know if you are interested in meeting! E.g. here or via email where I am more responsive 🤗

Achira is growing! We’re looking for talented software engineers, ML research engineers, and AI/ML scientists to join our team in building foundation simulation models to power the future of drug discovery. Apply at

this is an essay about cancer, how it is one of the most 'detailed' diseases in existence, and why we must delegate the understanding of that complexity to machine intelligence https://t.co/Gq2ikOpSXB 3.4k words, 15 minute reading time

Why are coding models so obsessed with backwards compatibility?

Do you hold legacy investment positions with significant gains? What if you could transition into an ETF without facing a large tax bill? You can, with a 351 ETF Exchange. Here’s how it works: Investors contribute stocks or other securities to a newly formed ETF in exchange for

Spent three years looking for a team in Biodefense to invest in. But never found one. So we built it ourselves. Valthos builds next-generation biodefense. As AI and biotech rapidly advance, we're approaching near-universal access to tools with the potential to cure humanity or

Thrilled to unveil @Lux_Capital incubation @ValthosTech - they're building next-generation biodefense powered by AI The team is truly fantastic - @kath_mcmahon built & led @PalantirTech's life sciences biz; @velvetatom pioneering our biosecurity thesis & more! 🦠👩‍🔬🚀

1/ I spent a long time at Palantir chasing hard problems with brilliant people (can recommend). So I think I know a good quest when I see it. Excited to announce that I started Valthos with @velvetatom and an incredible team

I'm fortunate to be a tiny investor in Valthos, because I believe it is critical infrastructure for the world. If you agree, one way you can help is by amplifying their launch post:

I made an App that can shrink almost any file locally.

I've gotten to see Valthos come to life over the past few years, and this is a special team: - scientists from the world's top genomics institute - top engineers from Palantir - researchers from DeepMind and other top labs It's time to grow the team.

When I started my company, I became extremely focused on one problem. But I told @wolfejosh the OTHER problem I would consider working on was biodefense. Why? Progress is accelerating. We must stay in control of our own biology.

How can we secure our own biology in an age of superintelligence? Valthos just raised $30 million from Lux Capital, Founders Fund, and OpenAI to be certain this century of biology goes well. If you're an engineer, please consider working on this. (more thoughts below)

OpenAI, Founders Fund and Lux Capital are backing a new company that aims to detect and counter bioweapon attacks

Valthos builds next-generation biodefense. Of all AI applications, biotechnology has the highest upside and most catastrophic downside. Heroes at the frontlines of biodefense are working every day to protect the world against the worst case. But the pace of biotech is against

I am specifically looking for a talented early career researcher (or engineer looking to break into research)! - Fast ramp-up to work on frontier capability evaluation at pre-training & post-training stages - Abundant technical mentorship and exposure to major model labs -

I attended the 2025 Progress Conference and had a lot of interesting conversations about agentic AI for science, which prompted me to write down some thoughts I've been developing on this topic. Here's seven thoughts on the future of "AI scientists":

I’m excited to join Cohort 1 of the Encode: AI for Science Fellowship (via @pillar_vc, @ARIA_research, @SciTechGovUK). Have enjoyed getting to know the other fellows — a group uniquely motivated to solve tough, important problems with AI. Check out our projects below! 👇🏽

Come join @maya_m_arce @uchemedoh @zhou_jingtian and start your lab at @arcinstitute as a Science Fellow! Researchers receiving their PhD, MD, or MD/PhD between spring 2024 and summer 2026, are encouraged to apply. Applications are being reviewed starting January 12, 2026.